"Economics, location, building dynamics and high-quality owner/management drove this deal," says David Dusek, senior managing director at Studley, in a release. "After an extensive search, we ascertained that it made the most sense for Genzyme to remain in place because of the building's infrastructure, which meets the company's requirements for HVAC, power, laboratory space and temperature control systems."
Dusek tells GlobeSt.com that other options that were scouted included sites in lower Westchester County--where Long Island-based biotech firm OSI will relocate--northern New Jersey, Brooklyn and locations in Manhattan, including the Hudson Square neighborhood, the forthcoming East River Science Park and other properties on the West Side.
Genzyme has been located at 521 W. 57th since 2004, when it acquired building tenant Impath Technology in a bankruptcy sale. Dusek says in a release that it's the company's long-term strategic plan to grow the business at its New York City hub.
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.